Fate of Syria Resolution Remains Uncertain in U.S. Senate, House

Global Security Newswire Staff
Add to Briefcase
See more stories about...
Global Security Newswire Staff
Sept. 5, 2013, 9:02 a.m.

It re­mained un­clear on Thursday wheth­er a U.S. Sen­ate com­mit­tee-passed res­ol­u­tion on use of force against Syr­ia would win en­dorse­ment on the Sen­ate floor or if an al­tern­ate meas­ure would pass in the House of Rep­res­ent­at­ives, which are ex­pec­ted to de­bate po­ten­tial strikes against the Middle East na­tion next week, USA Today re­por­ted.

The Sen­ate For­eign Re­la­tions Com­mit­tee on Wed­nes­day backed Pres­id­ent Obama’s pro­pos­al to em­ploy armed force against Pres­id­ent Bashar As­sad’s re­gime, the Wall Street Journ­al re­por­ted.

Obama’s high-stakes polit­ic­al push for mil­it­ary in­ter­ven­tion in Syr­ia has gained little trac­tion among GOP mem­bers of the lower cham­ber, des­pite win­ning the sup­port of House Speak­er John Boehner (R-Oh.) and Ma­jor­ity Lead­er Eric Can­tor (R-Va.) earli­er this week. Some of the pres­id­ent’s long­time Demo­crat­ic al­lies also are among the pro­pos­al’s greatest crit­ics, the New York Times re­por­ted on Wed­nes­day.

Ques­tions also per­sisted on the scope and tac­tics of a pos­sible at­tack, ac­cord­ing to the Journ­al. The text ap­proved on Wed­nes­day by the Sen­ate com­mit­tee states that any mil­it­ary ac­tion against As­sad’s gov­ern­ment should last no longer than 90 days. However, it would also com­mit Wash­ing­ton to al­ter­ing “the mo­mentum on the bat­tle­field” in Syr­ia’s civil war, now in its third year.

Des­pite the pro­posed strike’s stated aim of pun­ish­ing As­sad’s re­gime for al­legedly us­ing nerve gas to kill more than 1,400 people late last month and de­ter­ring fu­ture such at­tacks, Sec­ret­ary of State John Kerry said the ac­tion would have a “down­stream col­lat­er­al be­ne­fit” of erod­ing the Syr­i­an gov­ern­ment’s armed forces cap­ab­il­it­ies.

The De­fense De­part­ment pre­vi­ously said it would not plan to em­ploy bomber air­craft in a po­ten­tial at­tack, but the Pentagon is now ex­amin­ing pos­sible use of such planes in ad­di­tion to four mis­sile-equipped war­ships fielded off the Syr­i­an coast, the Journ­al re­por­ted. An of­fens­ive might in­volve mis­sile-cap­able B-1 or B-52 bombers, or B-2 air­craft able to ac­com­mod­ate large grav­ity mu­ni­tions.

What We're Following See More »
HE WAS 85
Former Rep. Joseph McDade Dies
1 hours ago
THE DETAILS

Former Rep. Joseph McDade, an 18-term Republican congressman who was known for bringing federal dollars home to his northeastern Pennsylvania district and who was acquitted in 1996 on a bribery charge," died Sunday. He served in the House from 1963-99 and was a senior member of the Appropriations Committee.

Source:
ANALYSIS INCOMPLETE DUE TO DEADLINE
CBO: “Millions” Would Lose Coverage Under Graham-Cassidy
3 hours ago
THE LATEST

"The Congressional Budget Office projected Monday that the last-ditch GOP ObamaCare repeal bill would result in 'millions' of people losing coverage. The agency did not give a specific number given a lack of time to do the analysis before a vote." CBO also said the bill would reduce deficits by $133 billion over ten years.

Source:
END OF THE ROAD
Susan Collins a “No” on Graham-Cassidy
3 hours ago
WHY WE CARE
ASKS ATTORNEYS IF THE ISSUE IS MOOT
Supreme Court Removes Travel Ban Case from Calendar
6 hours ago
THE LATEST

"The Supreme Court on Monday dropped the dispute over President Trump's travel ban from its oral argument calendar. The high court directed attorneys for both sides to submit 10-page briefs on whether they view the case as moot by noon on Oct. 5. Both sides must address whether the expirationof Trump's travel ban order on Sunday rendered the case moot and whether the new order from the president renders the existing litigation moot."

Source:
PROTESTERS BEING ARRESTED
Graham-Cassidy Hearing Recesses
7 hours ago
THE DETAILS
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login